Dolon is a leading, strategic consultancy specialising in pricing and market access for rare disease medicines. 

We partner and provide strategic guidance to global and national pharmaceutical companies on a variety of market access and policy issues globally. Our goal is to ensure that effective rare disease treatments are made accessible to the patients who need them, in a way that is sustainable for both the pharmaceutical industry and society.

Our market access specialists deliver solutions at a therapy, disease, portfolio and industry level to realise success throughout the product life cycle. We provide services in the following areas:

•	Value, Price and Access
•	Market Access Policy
•	Data and Analytics

Headquartered in London, and with offices globally, we are a team of enthusiastic and intellectually curious individuals who share a passion for collaboration and solving complex problems. 


Consulting

Health Care

Life Sciences

Pharmaceutical

Dolon Ltd

Adam Hutchings

Vilius Floreskul

Christina Palaska

Richard Dutton

Anna Albiero

Carina Bloxham

Emily Lewis

Melissa Whelan - McIpd

Dolon Ltd

Org chart

Teams

Offices

Dolon Ltd

Org chart

Teams

Offices

Related companies